Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology
-
Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
-
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
-
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Public Affairs, Reputation and Issues Management Expert Joshua Baca Joins FTI Consulting
-
Lightwave Logic, Inc. to Attend 28th Annual Needham Growth Conference
-
Det-Tronics Acquires Optronics
-
Form 8.3 - [IDOX PLC - 07 01 2026] - (CGWL)
-
Form 8.3 - Idox Plc
-
Form 8.3 - Empiric Student Property Plc
-
Renegade Gold Announces Arrangement of Debt Settlement and Engagement of Resource Stock Digest
-
Form 8.3 - [IDOX PLC - 07 01 2026] - (CGAML)
-
Ukrainian Journalists Learn How to Report During a Drone Attack, Through a Program Supported by The Globe and Mail Foundation
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Exodus Movement, Inc. December 2025 Treasury Update and Monthly Metrics
-
Withdrawal of Letter of Intent - IDOX plc - 08 01 2026 - (CGAML)
-
Gilat to Participate in the 28th Annual Needham Growth Stock Conference on Tuesday, January 13
-
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Mill Creek Announces Groundbreaking of Amavi Northwest Austin
-
Aurora Spine Announces Issuance of Two U.S. Patents
-
Aurora Spine Announces Issuance of Two U.S. Patents
-
SRx Health Solutions Regains Compliance with NYSE
-
Former Acting Secretary of Homeland Security Chad F. Wolf Joins American Global Strategies as a Vice Chairman
-
7-Eleven, Inc. Makes Mornings Flavorful with New Breakfast Favorites and Limited-Time Deals
-
Artificial Intelligence Production in Space: PowerBank Shares Additional Update on Collaboration with Smartlink AI
-
Natural Grocers® Launches Free Three-Part Class Series to Help Customers Hack Their Health
-
Max Stock Limited Announces Immediate report on Termination of Shareholders' Agreement and Management Services Agreement
-
Scientology’s New Year 2026 Celebration Reviews Global Expansion of Social Programmes worldwide
-
AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0
-
Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
-
Benzinga Brings Real-Time Trade Signals and Market Context to Newsquawk Users
-
IntellaTriage Formalizes Nurse-First Care Team Coordination Service to Strengthen Daytime Care Delivery
-
Americas Gold and Silver Provides Update on Rapid Progress at Newly Acquired Crescent Silver Mine in Idaho
-
Enduro Metals Announces Results of Rock Sampling at the Newmont Lake Project, Golden Triangle, BC
-
Howard Hughes Holdings Inc. Announces Dates and Times for 2025 Fourth Quarter Earnings Release and Conference Call
-
AuMEGA Metals Identifies Several Gold and Base Metals Targets at Bunker Hill
-
SuperQ Quantum Files Provisional Patent for ChatQLM Multi-Backend Orchestration Breakthrough Consumer App for Quantum and Supercomputing
-
Rush Rare Metals Announces Renewed Letter of Intent for Proposed Merger
-
GreenLight Metals Reviews 2025 Achievements and 2026 Exploration Strategy
-
SchoolAI Research Challenges Fears About AI in the Classroom with Evidence From 23,000 Teacher-Created Lessons
-
MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million
-
Microchip Releases Custom Firmware For NVIDIA DGX Spark For Its MEC1723 Embedded Controllers
-
Adam Clermont Releases New Book - Profit Before People: When Corporations Knew It Was Dangerous and Sold It Anyway
-
Five Star Franchising lands two brands on Franchise Business Review's Top 200 Franchises list
-
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
-
Beacon Therapeutics Announces Closing of Oversubscribed Series C Financing for Over $75 Million
-
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
-
Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy
-
Destination Imagination Appoints Mark Giordono as Chief Executive Officer
